Founder, Chairman & CEO
Managing General Partner of NGN Capital since 2014. He had successful IPOs and M&A transactions in his investment portfolio. Prior to that, he was Head of Corporate Development at Boehringer Ingelheim (responsibilities: Strategic Planning, Projects, M&A, Business Development, Licensing - Identified and Evaluated of License, M&A and Co-Promotion Deals). Further references: Positions in marketing, business development, sales and product management (e.g. at F. Hoffmann-La Roche, Boehringer Mannheim, Kaneka, Röhm).
Senior Director, Business Development
Senior executive with more than 30 years of experience in medical devices in the fields of gastroenterology, minimally invasive surgery, ENT, respiratory therapy, urology, gynecology, and neurosurgery. He was Managing Director of YUKIO Advisors LLC (B2B consulting for medical device companies) and previously was with Olympus for a long time. Experience in the fields: Business development, strategic planning, technology evaluation, KOL relationships, international/intercultural business relationships, product development, and more.
Bonnie Eve Zdraveva
Clinical Educator Europe
Chief Financial Officer
25 years experience in clinical research, corporate development, private equity and investment banking. His career began with significant contributions in the CRO sector at IBAH, Inc. He also served in global investment banking teams (Deutsche Bank; UBS), where he played a significant role in over $50 billion of M&A and financing transactions. As Managing Director for Fosun International, he made investments in the US and European healthcare sectors.
Member BOD, Lumendi Ltd.
After graduating in law from the University of Bern, he was employed by a firm of attorneys in Chur and, thereafter, joined the administrative court of the Canton of Grison, Switzerland. After spending time in Paris and Florence in order to perfect his French and Italian language skills, he found employment in a large trust company in the Principality of Liechtenstein. While working there he became head of department of professional advisors/trust officer senior. After 6 years he was invited to become a partner in the Lichtenstein trust company.
Member BOD, Lumendi Ltd.
He sits on several boards such as Montana Capital Partners AG and Rhino Partners For 17 years, he was CEO of Hirslanden Group being instrumental in growing the company from a hospital to one of Europe’s largest and most successful private hospital chains. He is further a member of the board of Grand Hotels Bad Ragaz, Salem-Spital, Beau-Site AG, USI Group Holdings AG, Medi-Clinic Switzerland AG and Medi-Clinic Corporation Limited.